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Abstract Varicella-zoster virus (VZV) causes varicella
(chickenpox), becomes latent in ganglia along the entire
neuraxis, and may reactivate to cause herpes zoster (shin-
gles). VZV may infect ganglia via retrograde axonal trans-
port from infected skin or through hematogenous spread.
Simian varicella virus (SVV) infection of rhesus macaques
provides a useful model system to study the pathogenesis of
human VZVinfection. To dissect the virus and host immune
factors during acute SVV infection, we analyzed four SVV-
seronegative Chinese rhesus macaques infected intratra-
cheally with cell-associated 5×10
3 plaque-forming units
(pfu) of SVV-expressing green fluorescent protein (n02)
or 5×10
4 pfu of wild-type SVV (n02). All monkeys devel-
oped viremia and SVV-specific adaptive B- and T-cell im-
mune responses, but none developed skin rash. At necropsy
21 days postinfection, SVV DNA was found in ganglia
along the entire neuraxis and in viscera, and SVV RNA
was found in ganglia, but not in viscera. The amount of
SVV inoculum was associated with the extent of viremia
and the immune response to virus. Our findings demonstrate
that acute SVV infection of Chinese rhesus macaques leads
to ganglionic infection by the hematogenous route and the
induction of a virus-specific adaptive memory response in
the absence of skin rash.
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Introduction
Varicella-zoster virus (VZV) is an exclusively human ubiq-
uitous neurotropic alphaherpesvirus. Primary infection usu-
ally causes varicella (chickenpox), after which the virus
becomes latent in neurons of sensory ganglia along the
entire neuraxis. Primary VZV infection typically results in
a generalized maculopapular vesicular rash, although some
infected individuals never develop rash (Heininger and
Seward 2006). During primary infection, virus is trans-
ported from the respiratory mucosa to sites of secondary
replication and skin via VZV-infected lymphocytes (Asano
et al. 1985; Ozaki et al. 1994). Virus reaches ganglia either
by retrograde axonal transport from infected skin or by
hematogenous spread via VZV-infected lymphocytes
(Annunziato et al. 2000; Reichelt et al. 2008). Reactivation
of latent VZVresults from a decline in virus-specific cellular
immunity (Miller 1980), mostly in elderly individuals as
well as in immunocompromised organ transplant recipients
and HIV+patients, resulting in zoster and multiple other
serious neurological and ocular disorders (Gilden et al.
2000; Hope-Simpson 1965).
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human primates. Like VZV, SVV becomes latent in
ganglionic neurons (Gray et al. 1998; Kennedy et al. 2004;
Mahalingam et al. 1991) and may reactivate to produce zoster
(Mahalingam et al. 2007). SVV and VZV antibodies
cross-react, and open reading frames (ORFs) of the two
viruses share amino acid identity ranging from 27.3% to
75.4% (Gray et al. 2001). Intrabronchial inoculation of SVV
into seronegative Indian rhesus macaques produces patholog-
ical and immunological features like those seen in primary
VZVinfection in humans (Messaoudi et al. 2009). The aim of
the present study was todissect virus and hostimmunefactors
after primary SVV infection of Chinese rhesus macaques.
Materials and methods
Cells and viruses
Wild-type SVV (SVV-WT) and SVV expressing green
fluorescent protein (SVV-GFP) were used. SVV-WT
(Delta herpesvirus strain) was originally isolated from a
naturally infected monkey (Erythrocebus patas;M a h a l i n g a m
et al. 1992). SVV-GFP is not attenuated in vitro or in vivo
(Mahalingam et al. 2001; Mahalingam et al. 1998). Low-
passage SVV isolates were obtained from peripheral blood
mononuclear cells (PBMC) of acutely infected African
green monkeys and propagated <5 times either in a fetal
rhesus macaque lung fibroblasts (DBS-FRhL-2) to generate
cell-associated SVV-GFP and wild-type stocks for intra-
tracheal inoculation or in Vero cells to produce wild-type
SVV protein lysates for ELISA and functional T-cell
assays (Mahalingam et al. 2001;M a h a l i n g a me ta l .1998).
Protein lysates were identically prepared from mock-infected
DBS-FRhL-2.
Macaque studies
Four juvenile (3 to 4 years old) SVV-seronegative Chinese
rhesus macaques were inoculated intratracheally at the bron-
chial bifurcation with 5×10
3 plaque-forming units (pfu) of
cell-associated SVV-GFP (animals 0075 and 2135) or 5×
10
4 pfu cell-associated SVV-WT (animals 2207 and 9021)
diluted to a volume of 5 ml in phosphate-buffered saline
(PBS). While the inoculation titers varied slightly, both virus
titers have been shown to produce viremia and skin rash in
Indian rhesus macaques (Mahalingam et al. 2010). Animals
were housed in negatively pressurized hepa-filtered BSL-3
isolator cages. Before inoculation, the abdomen and back of
the animals were shaved to allow careful examination for
rash every other day from 1 to 21 days postinfection (dpi).
Heparinized blood samples were collected at 0, 2, 5, 7, 9,
11, 13, 15, and 21 dpi. Plasma separated from the blood by
centrifugation was heat-inactivated (30 min at 56°C) and
stored at −20°C. PBMCs were isolated by density-gradient
centrifugation for flow cytometry, DNA, and RNA isolation
and functional B- and T-cell assays (see below). Animals
were euthanized at 21 dpi by sedation with ketamine
(20 mg/kg body weight) followed by exsanguination. Tissue
samples were snap-frozen in liquid nitrogen and stored
at −80°C. The study was approved by the Institutional
Animal Welfare Committee and performed according to
Dutch guidelines for animal experimentation.
Nucleic acid extraction and real-time PCR
DNA was extracted from PBMC, individual or pooled gan-
glia, and from portions of liver, lung and spleen using the
QIAamp DNA Mini Kit (Qiagen, Valencia, CA, USA).
Total RNAwas isolated from the same tissues using TRIzol
reagent (Invitrogen, Carlsbad, CA, USA) and subsequently
with the RNeasy Mini Kit (Qiagen). cDNA synthesis was
performed as described (Messaoudi et al. 2009) using 1 μg
total RNA and Superscript III RT (Invitrogen) with random
primers. Quantitative real-time PCR (qPCR) was performed
in triplicate on DNA and cDNA using Taqman 2× PCR
Universal Master Mix (Applied Biosystems, Foster City,
CA, USA) with primers and probes specific for SVV DNA
ORFs 21, and ORFs 9, 61, and 63 (cDNA) as described
(Messaoudi et al. 2009). SVV DNA amplicons were includ-
ed in each qPCR assay and yielded a consistent inverse
relationship between the Ct value and the amount of input
template DNA. The detection limit of the SVV DNA qPCR
assay, based on the ORF21 primers/probe set, was 1 copy
SVV DNA/μg DNA (Fig. 1a). Single-copy gene oncostatin-
M (OSM) and GAPDH (glyceraldehyde-3-phosphate
Fig. 1 Detection of SVV DNA in blood leukocytes of SVV-infected
Chineserhesus macaques.a The efficiency ofSVVDNA quatitationwas
determined in real-time PCR using 1 to 10x10
10 copies of SVV ORF21
mixed with 100 ng of herring sperm DNA. The SVV ORF21 primer set
reliably detected 1 to 10×10
10 copies of SVV DNA (r
200.999). b SVV
DNA levels were determined using real-time PCR with primers specific
for SVV ORF 21. All monkeys were positive for SVV DNA, with peak
viremiaoccurringat5dpi.SVVDNAcopynumbervariedfromverylow
(monkeys 0075 and 2135) to high (monkeys 2207 and 9021)
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and RNA integrity, respectively, according to the manufac-
turer’s instructions and as described (Bruce et al. 2005).
SVV-specific ELISA
Plasma SVV-specific IgG titers were determined by ELISA.
Briefly, 96-well flat-bottom plates were coated with protein
lysates of mock- and SVV-infected Vero cells (2 μg/ml) over-
night at 4°C, washed twice with distilled water, and blocked
with 3% bovine serum albumin (BSA) diluted in PBS for 1 h
at37°C.Three-folddilutionsofplasmasampleswereprepared
in PBS containing 1% BSA and incubated for 1 h at 37°C.
After 10 washes with 0.05% Tween 20 in PBS, the wells were
incubated with horseradish peroxidase (HRP)-conjugated rab-
bit anti-human IgG (DakoCytomation) diluted in 1% BSA in
PBS for 1 h. The plates were washed 10 times and incubated
with the substrate 3, 3′,5 ,5 ′-etramethylbenzidine at room
temperature. After 10 min, the reaction was stopped by addi-
tion of 2 M sulfuric acid, and optical density (OD) was
measured at 405 nm using 620 nm as a reference. End-point
titers were obtained by log-log transformation of the linear
proportion of the curve using 0.2 OD units as a cut-off.
Virus neutralization assay
Plasma SVV neutralization IgG titers were determined by
plaque reduction assay on Vero cells as described (Soike et
al. 1991). Briefly, serial 2-fold dilutions of heat-inactivated
macaque plasma samples were incubated with ~100 pfu of
SVV for 1 h at room temperature. Plasma samples were
plated in duplicate on confluent Vero cells in 6-well plates.
After 7 days of culture at 37°C, monolayers were fixed in
4% paraformaldehyde and stained with 0.2% crystal violet
solution to visualize virus plaques. The SVV neutralizing
titer was expressed as the highest dilution showing an 80%
reduction in virus plaques compared to control samples
cultured in the absence of plasma.
Flow cytometry
PBMCs were stained with monoclonal antibodies (mAbs)
directed against human CD20 (clone L27; BD Biosciences,
San Diego, CA, USA), IgD (Southern Biotech, Birming-
ham, AL, USA), and CD27 (O323; BD Biosciences) to
discriminate between naïve and memory B-cell subsets
(Messaoudi et al. 2009;V u g m e y s t e re ta l .2004). T-cell
subsets were identified using mAbs directed against human
CD3 (SP34-2), CD4 (L200), CD8 (SK1), CD28 (CD28.2),
and CD95 (DX2) (all BD Biosciences) to distinguish be-
tween naïve, central memory and effector memory T-cells
(Messaoudi et al. 2009; Pitcher et al. 2002). Cells were fixed
in Cytofix/Cytoperm (BD Biosciences) and stained with
antibodies against granzyme B (grB; GB11; BD Bioscien-
ces) to detect cytotoxic T-cells. To detect proliferating B-
and T-cells, the nuclear membrane was permeabilized using
10% DMSO in Cytofix/Cytoperm (BD Biosciences), and
cells were stained with antibody directed against the cell
proliferation marker Ki67 (clone B56; BD Biosciences).
Fluorescence was detected on a FACS Canto II and ana-
lyzed using FACS Diva software (BD Biosciences).
Detection of SVV-specific T-cells
PBMCs were stimulated overnight with predefined optimal
concentrations of protein lysates generated from mock and
SVV-infected Vero cells, and mock-infected DBS-FRhL-2
cells, followed by incubation with Golgistop (BD Bioscien-
ces) for 6 h at 37°C to block cytokine secretion. After stimu-
lation, cells were stained with mAbs directed against human
CD3, CD4, CD8, CD28, and CD95 as described above.
Samples were fixed and permeabilized using Cytofix/Cyto-
perm and incubated with a human interferon (IFN)-γ-specific
mAb B27(BD Biosciences).Fluorescencewasmeasured ona
FACS Canto II and analyzed using FACS Diva software.
Results
Clinical course of acute SVV infection in Chinese rhesus
macaques
To investigate the virus and host immune factors during
acute SVV infection, four SVV naïve Chinese rhesus mac-
aques were infected intratracheally with 5×10
4 pfu cell-
associated SVV-WT (n02) or 5×10
3 pfu SVV-GFP (n02).
SVV-GFP was used to enable visualization of SVV-infected
cells in blood during viremia and in skin lesions. Physical
examinations every other day revealed no skin lesions. All
animals developed a viremia. SVV DNA levels were higher
in monkeys 2207 and 9021 that received the highest SVV
dose, compared to animals 0075 and 2135 that received a
lower dose of SVV and had trace levels of SVV DNA in
peripheral blood mononuclear cells (PBMCs; Fig. 1b). SVV
DNA was detected 2 to 15 dpi and peaked at 5 dpi. No
infectious SVV was recovered from PBMCs at any time
during viremia, and no SVV- or GFP-positive cells were
detected by flow cytometry in whole-blood (data not shown).
Detection of SVV DNA and RNA in ganglionic
and non-ganglionic tissues of SVV-infected rhesus
macaques
To determine if SVV ganglionic infection was inhibited by
the absence of overt viral replication in skin, the SVV DNA
load in dorsal root ganglia and trigeminal ganglia at 21 dpi
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in most pooled ganglia, indicating hematogenous infection.
The SVV DNA load was higher in monkeys infected with
higher doses of virus (monkeys 2207 and 9021). SVV DNA
load in non-ganglionic tissues (i.e., lung, liver, and spleen)
was undetectable or lower compared to ganglia of the same
monkey (Tables 1 and 2).
Like VZV latency in humans, SVV latency is associated
withtherestrictedtranscription ofseveral immediateearlyand
early transcripts (Kennedy and Cohrs 2010; Kennedy et al.
2004). Levels of the SVV latency-associated ORF 61 and
ORF 63 transcripts, as well as the late SVV ORF 9 transcript
were determined in ganglia and non-ganglionic tissues of all
monkeys. No SVV transcripts were detected in lung, liver and
spleen (Table 2). SVV ORF 61 was the most prevalent and
abundant SVV transcript found in ganglia (Table 1). Lower
levels of SVV ORF 63 transcripts were detected in ganglia
fromallbutonemonkey(0075)thatalsohadalowSVVDNA
load. Trace levels of SVV ORF 9 transcripts were detected in
ganglia of 3 of 4 monkeys. The detection of low levels of the
late SVV gene ORF 9 transcript, along with higher levels of
SVV latency-associated transcripts in monkey 9021 indicated
that latency was not completely established at 21 dpi.
B-cell response in SVV-infected rhesus macaques
All monkeys had detectable plasma SVV-specific IgG
titers at 7 dpi, which peaked between 9 and 11 dpi and
remained high until the end of the 21-day study period
(Fig. 2a). Comparable levels of SVV-specific plasma
IgG titers were found in all monkeys and monkeys 2207
and 9021 developed virus-neutralizing antibody titers ≥1:10
(Fig. 2b).
Upon antigen recognition, antigen-specific B-cells pro-
liferate and mature into isotype-switched memory B-cells
and plasma cells (Srivastava et al. 2005). To identify prolif-
erating B-cell subsets, CD20
+ cells were divided into naïve
(IgD
+CD27
−) and memory (IgD
−CD27
+) B-cells using flow
cytometry (Fig. 2c) and stained for the proliferation marker
Ki67 (Scholzen and Gerdes 2000; Vugmeyster et al. 2004).
Compared to 0 dpi, only a marginal increase (1.2- to 1.5-
fold) in proliferating memory B-cells was seen in 3 of 4
monkeys from 9 to 11 dpi (Fig. 2d).
T-cell response in SVV-infected rhesus macaques
Primary VZVinfection in humans induces a profound T-cell
mediated immune response, which occurs after the onset of
varicella skin rash and is essential in controlling viremia
(Weinberg and Levin 2010). Upon recognition of the
cognate antigen, T-cells proliferate and mature to memory
T-cells. To assess T-cell expansion in SVV-infected rhe-
sus macaques, blood-derived T-cells (CD3
+ cells) were
differentiated into naïve (CD28
+CD95
−), central memory
(CD28
+CD95
+) and effector memory (CD28
−CD95
+;
Pitcher et al. 2002) and stained for Ki67 (Fig. 3ai, ii).
Table 1 Quantification of SVV-
specific DNA and transcripts in
ganglia from Chinese rhesus
macaques at 21 days post
infection
aSVV genome copies/ug of total
DNA
bSVV transcript copies/μg of to-
tal RNA.
cOncostatin-M
dGlyceraldehyde 3-phosphate
dehydrogenase.
eSpecific amplicon detected.
fNot done
g>2 copies of SVV DNA or
cDNA in 1 or 2 out of 3 reactions
hSVV DNA or transcript
undetectable.
iPooled lumbar and sacral ganglia
Monkey Ganglion DNA target
a RNA target
b
ORF 21 OSM
c ORF 9 ORF 61 ORF 63 GAPDH
d
0075 Trigeminal 6 positive
e nd
f nd nd nd
Cervical 0 positive nd nd nd nd
Thoracic 0 positive nd nd nd nd
Lumbar trace
g positive und
h 3 und positive
Sacral 4 positive und 8 und positive
2135 Trigeminal 28 positive nd nd nd nd
Cervical 8 positive trace 81 trace positive
Thoracic 117 positive trace 372 6 positive
Lum/Sac
i 16 positive trace 138 trace positive
2207 Trigeminal 60 positive nd nd nd nd
Cervical 2 positive trace 75 7 positive
Thoracic 73 positive nd nd nd nd
Lumbar 99 positive und 15 trace positive
Sacral 38 positive nd nd nd nd
9021 Trigeminal 860 positive nd nd nd nd
Cervical 230 positive und 582 trace positive
Thoracic 687 positive nd nd nd nd
Lumbar 698 positive trace 692 trace positive
Sacral 64 positive 9 8089 239 positive
94 J. Neurovirol. (2012) 18:91–99Intratracheal inoculation with cell-associated SVV induced
proliferation of CD4
+ and CD8
+ T-cells in the central
and effector memory compartments of all rhesus macaques
at 7 dpi (Fig. 3b). More proliferation was induced in CD8
+
compared to CD4
+ T-cells, and more proliferating CD8
+
T-cells were found in monkeys that received the highest
virus dose (monkeys 2207 and 9021). VZV infection
also induces virus-specific cytotoxic CD4
+ and CD8
+
T-cells that express granzyme B (grB) and secrete soluble
mediatorssuchasIFN-γ(Haywardetal.1996; Malavige etal.
2007). Intratracheal inoculation with cell-associated SVV
resulted in an increase in grB-expressing CD4
+ and CD8
+
central but not effector memory T-cells, with the highest
numbers seen at 7 dpi; induction of grB
+CD8
+ central mem-
ory T-cells was found only in monkeys 2207 and 9021
(Fig. 3c).
The Ki67 and grB response shown in Fig. 3b,c
might have been induced by either viral proteins or
allogeneic major histocompatibility complex (MHC)
proteins expressed by uninfected DBS-FRhL-2 cells
used to generate the SVV inoculum. Thus, the frequen-
cy of antigen-specific T-cells was determined by intra-
cellular staining for IFN-γ at all time points in all
monkeys using various control cell lysates (Fig. 3aiv,
d). First, we included protein lysates of mock- and
SVV-infected Vero cells to differentiate T-cell reactivity
directed against SVV antigens. Second, T-cell reactivity
directed towards proteins lysates of mock-infected DBS-
FRhL-2 cells was assayed to detect the induction of
allo-MHC specific T-cell responses after intratracheal
inoculation of cell-associated SVV in rhesus macaques.
While no MHC response was detected, the SVV-specific
memory CD4+ T-cell response was detected starting at
9 dpi (Fig. 3d). Analogous to the frequency of grB+T-
cells, most IFN-γ-secreting CD4
+ T-cells had a central
memory phenotype (Fig. 3aiv data not shown) as was
also seen in grB
+ T-cells (Fig. 3c). Overall, all monkeys
Table 2 Quantification of SVV-
specific DNA and transcripts in
non-ganglionic tissues from
Chinese rhesus macaques at
21 days post infection
aSVV genome copies/ug of total
DNA
bSVV transcript copies/μg of to-
tal RNA
cOncostatin-M.
dGlyceraldehyde 3-phosphate
dehydrogenase.
eSpecific amplicon detected
fSVV DNA or transcript
undetectable
Monkey Tissue DNA PCR
a cDNA PCR
b
ORF 21 OSM
c ORF 9 ORF 61 ORF 63 GAPDH
d
0075 Lung 3 positive
e und
f und und positive
Liver und positive und und und positive
Spleen und positive und und und positive
2135 Lung und positive und und und positive
Liver und positive und und und positive
Spleen und positive und und und positive
2207 Lung und positive und und und positive
Liver und positive und und und positive
Spleen und positive und und und positive
9021 Lung und positive und und und positive
Liver 3 positive und und und positive
Spleen 1 positive und und und positive
Fig. 2 Induction of SVV-specific B-cell response in infected Chinese
rhesus macaques. a SVV-infected macaques developed a SVV-specific
plasma IgG response starting at 7 dpi, peaking at 9 to 11 dpi and
remaining high until 21 dpi as determined by SVV ELISA. b SVV
neutralizing antibodies were detected in animals 2207 and 9021 start-
ing at 9 dpi. c Peripheral blood B-cells identified by flow cytometry
based on expression of CD20 were further distinguished as naïve
(IgD
+CD27
−) or memory (MEM; IgD
−CD27
+) B-cells. d Proliferation
of memory B-cells as assessed by flow cytometry based on expression
of the cell proliferation marker Ki67 and given as fold-increase in Ki67
+ cells compared to the sample obtained at 0 dpi
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beginning about 4 days after the peak in viremia.
Discussion
The present study showed that after primary infection
with SVV, Chinese rhesus macaques developed viremia,
ganglionic infection by the hematogenous route and
virus-specific memory B- and T-cell responses in the
absence of rash. The absence of rash contrasts with
previous studies, which showed that inoculation of In-
dian rhesus macaques deep into the bronchial tree with
similar virus loads of the same SVV strain lead to
viremia, SVV-specific adaptive immune responses and
varicella rash at 7–10 dpi (Mahalingam et al. 2010;
Messaoudi et al. 2009). While both the trachea and
bronchi harbor cells susceptible to SVV infection, the
anatomic location within the respiratory tract at which
the virus is administrated might affect initial virus rep-
lication. Alternatively, the geographic origin of rhesus
macaques may affect their susceptibility to SVV infec-
tion. Whole-genome sequencing has revealed extensive
genetic differences in rhesus macaques of Indian and
Chinese origin (Gibbs et al. 2007; Hernandez et al.
2007) that are likely to play a role in the different
disease progression and host response seen after SIV
infection (Ling et al. 2002; Trichel et al. 2002).
VZV in humans is thought to enter ganglia either via
hematogenous transport within infected lymphocytes or by
retrograde axonal transport from varicella skin lesions
(Annunziato et al. 2000; Ozaki et al. 1994). The latter notion
is based largely on studies with herpes simplex virus, while
only indirect evidence exists for VZV. For example, VZV
ORF29 protein is expressed in Schwann cells and axons of
nerves in varicella, but not in zoster lesions (Annunziato et
al. 2000). Also, VZV can infect axons and undergo retro-
grade transport to neuronal cell bodies in vitro (Markus et al.
2011). The data presented herein reveal that SVVreplication
in the skin of intratracheally infected rhesus macaques is not
a prerequisite for virus to infect ganglia. The association
between SVV DNA loads in blood and ganglia further
supports the role of SVV-infected lymphocytes in the estab-
lishment of ganglionic infection. Similarly, the high corre-
lation of VZV seropositivity with the presence of VZV
DNA in ganglia (Verjans et al. 2007) indicates subclinical
hematogenous infection in VZV seropositive humans with-
out a history of chickenpox.
Compared to SVV infection of Indian rhesus mac-
aques (Messaoudi et al. 2009), a dampened adaptive
B- and T-cell response, with reduced peak endpoint
SVV-specific IgG titers, a lower proliferative B-cell re-
sponse and a lower frequency of proliferating T-cells
and SVV-specific T-cells were seen after SVV infection
of Chinese rhesus macaques. Note that live attenuated
VZV Oka vaccine typically does not cause varicella
rash in humans and elicits an immune response that is
less robust than that seen after natural VZV infection
(Watson 2008; Weinberg et al. 2010), although it is
protective (Hayward et al. 1996; Levin et al. 1994;
T a k a h a s h ie ta l .1974). The kinetics of the T-cell re-
sponse found herein is similar to that found by Messaoudi
et al. (2009), who reported a peak in T-cell proliferation
and grB expression shortly after peak viremia in mac-
aques. However, the SVV-specific immune response
herein was dominated by T-cells exhibiting a central
memory rather than an effector memory phenotype,
consistent with studies on the phenotype of VZV-
specific T-cells in humans which express the co-
stimulatory molecule CD28 and the lymph node-
homing receptors CCR7 and CD62L (Malavige et al.
2008a, b). The marked similarities between SVV infec-
tion in rhesus macaques and humans vaccinated with
the varicella vaccine emphasize the applicability of this
animal model to develop novel therapeutic strategies against
VZV infection.
Overall, our results demonstrate that acute SVV in-
fection of Chinese rhesus macaques leads to ganglionic
infection and the induction of a virus-specific adaptive
B- and T-cell memory response in the absence of skin
rash. Importantly, some humans have serum antibody to
VZV without any history of varicella. Yet VZV is latent
in ganglia of nearly all humans. A logical interpretation
of these facts is that human ganglia are infected hema-
togenously, a notion supported by our demonstration that
ganglia of Chinese rhesus macaques are infected hematoge-
nously by SVV.
Fig. 3 Induction of systemic SVV-specific T-cell response in
infected Chinese rhesus macaques. ai Peripheral blood T-cells
were identified based on expression of CD3 and categorized
further based on expression of CD28 and CD95 as naïve
(CD28
+CD95
-) ,c e n t r a lm e m o r y( C M ;C D 2 8
+CD95
+) and effector
memory (EM; CD28
−CD95
+) T-cells. aii Proliferating T-cells were
identified by flow cytometric detection of cell proliferation marker
Ki67, shown for CM CD4
+ T-cells from animal 9021 at 0 (filled
area)a n d9( black line)dpi. aiii Granzyme B expression in CM
CD4
+ T-cells from animal 2207 at 0 (filled area)a n d7( black
line)dpi. aiv SVV-specific IFN-γ-producing memory CD4
+ T-cells
from animal 9021 at 21 dpi. b Kinetics of proliferation in T-cell
subsets, with a peak in proliferation of CM and EM CD4
+ at
7d p ia n dp e a kp r o l i f e r a t i o ni nC Ma n dE MC D 8
+ T-cells at 7 to
9 dpi and 7 to 11 dpi, respectively. c Kinetics of granzyme B
expression in T-cell subsets, showing a relative increase in CM
CD4
+ and CD8
+ at 7 dpi. d Percentage of IFN-γ producing
peripheral blood memory CD4
+ T-cells in response to protein lysates
prepared from mock- and SVV- infected Vero cells (netto responses are
shown in black bars) and mock-infected rhesus macaque FRhL-2 cells
(white bars)
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